Engineering Nanocarriers for siRNA Delivery

Small. 2011 Apr 4;7(7):841-56. doi: 10.1002/smll.201001389. Epub 2011 Feb 25.

Abstract

The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy for the treatment of diseases. Nevertheless, despite promising results from experimental studies, there remains a pressing need for the development of nanocarriers that are clinically-relevant, biocompatible, efficient, and that can be tailored to specific disease targets. This review surveys the broad spectrum of nanomaterials and their functional add-ons, and aims to provide a guide towards engineering nanocarriers for effective siRNA delivery.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Genetic Therapy / methods
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Neoplasms / therapy
  • RNA Interference
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / therapeutic use

Substances

  • RNA, Small Interfering